Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIMESULIDE vs NINTEDANIB ESYLATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIMESULIDE vs NINTEDANIB ESYLATE: Safety Overview

Metric NIMESULIDE NINTEDANIB ESYLATE
Total FAERS Reports 996 117
Deaths Reported 244 23
Death Rate 24.5% 19.7%
Hospitalizations 408 39
Average Patient Age 49.7 yrs 66.4 yrs
% Female Patients 66.5% 47.8%
FDA Approval Date N/A Oct 15, 2014
Manufacturer N/A Boehringer Ingelheim Pharmaceuticals,...
Route N/A ORAL
Marketing Status N/A Prescription